4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 985.00
-17.50 (-1.78%)
Jun 27, 2025, 4:35 PM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 152.45 million as of June 27, 2025. Its market cap has decreased by -21.67% in one year.
Market Cap
152.45M
Enterprise Value
132.84M
Revenue
933.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
985.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 152.45M, an increase of 266.72%. That is a compound annual growth rate of 34.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 152.45M | -1.61% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.21B |
| GSK plc | 57.08B |
| Haleon | 34.40B |
| Smith & Nephew | 9.56B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.55B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.28B |